All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

Lisinopril Dihydrate

Dangerous Goods

CAS number:83915-83-7    molecular formula:C21H31N3O5· 2H2O

overview

compound introduction

Lisinopril 是血管紧张素转换酶抑制剂,用于治疗高血压,充血性心脏衰竭及心脏病发作,并能防止肾和糖尿病的视网膜并发症。 产品应用: 赖诺普利已被用于研究杜氏营养不良症小鼠的抗纤维化作用。它已被用于研究经过长期达贝泊汀处理后的 TGR(mRen2)27 (携带小鼠 Ren-2 基因的转基因大鼠)大鼠的肾结构和功能的变化。 Lisinopril is an angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks, and also in preventing renal and retinal complications of diabetes.

Specs

Chinese alias赖诺普利二水合物 | (S)-1- [N2-(1-羧基-3-苯丙基)-赖氨酰脯氨酸 二水合物 | 1-[Nα-[(S)-1-羧基-3-苯丙基]-L-赖氨酰基]-L-脯氨酸 二水合物
English aliasMK-521 | LISINOPRIL COMPONENT OF PRINZIDE | LISINOPRIL [USAN] | Prestwick_613 | (S)-Lisinopril | AC-6226 | UNII-E7199S1YWR | DTXSID7041253 | Lisinopril, United States Pharmacopeia (USP) Reference Standard | (S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-
CAS number83915-83-7molecular formulaC21H31N3O5· 2H2O
molecular weight405.49(as Anhydrous)Exact mass≥98%
PSA135.000 Ųlogp-

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

pictogram:
GHS08
Signal word:
Danger
Hazard Statement:
H373: 通过长时间或反复暴露对器官造成损害 H360: 可能损害生育力或未出生的孩子 H361: 怀疑破坏生育力或未出生的孩子
Statement of Preventive Measures:
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。 P319: 如果你感到不适,请寻求医疗帮助。
WGK Germany:
3
Personal protective equipment:
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
RTECS:
TW3589990

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 1 shareMSDS
83915-83-7 | Lisinopril dihydrate.pdf